The largest database of trusted experimental protocols

Leksell gamma knife perfexion

Manufactured by Elekta
Sourced in Sweden

The Leksell Gamma Knife Perfexion is a stereotactic radiosurgery system designed for precise, non-invasive treatment of brain disorders. It utilizes multiple precisely focused gamma ray beams to target and treat lesions or abnormalities in the brain.

Automatically generated - may contain errors

18 protocols using leksell gamma knife perfexion

1

Radiation-Induced Brain Necrosis in BALB/c Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female Balb/c mice were anesthetized using 1.5 L/min oxygen containing isoflurane (3% for induction, 2% for maintenance) and positioned on a custom-designed stereotactic bed [62 (link)] compatible with the Leksell Gamma Knife Perfexion (Elekta AB, Stockholm, Sweden). A maximum dose of 45 Gy (23.1 Gy at the 50% isodose) was delivered through 4 mm collimators in the right hemisphere of the brain. Mouse and human brains have different sensitivities to radiation. This dose was selected because it allows the development and slow progression of radiation necrosis (approximatively appearing at 17 months post-irradiation in T2-weighted MRI; Figure 4), similar to what may be observed in brain cancer patients who received radiotherapy [63 (link)]. After irradiation, mice were placed on a heating pad to recover, and were then returned to their cages.
+ Open protocol
+ Expand
2

Stereotactic Radiosurgery for Vestibular Schwannoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Leksell G stereotactic frame (Elekta instruments AB, Stockholm, Sweden) was fixed under local anesthesia and mild sedation, with specific attention given to avoiding the area of the previous posterior fossa craniotomy. All patients underwent stereotactic MRI (1.5 Tesla, Siemens, Erlangen, Germany) and computed tomography (CT) with bone windows. The MR sequences used are T1-weighted with and without gadolinium contrast medium and T2 CISS, without contrast medium (in small remnants) and/or with contrast medium (in larger remnants); T2 CISS with contrast medium helps to differentiate between the nerves and the tumor [24 (link)]. Target definition and treatment dosimetry were performed using Leksell GammaPlan® planning software version 10 or 11. The modiolus of the cochlea was defined on bone CT images and the dose received was further calculated (as the dose received by the first 1% of the volume, and as the maximum dose). If this dose was more than 4 Gy in patients with useful hearing, additional sector blocking was used to ensure that optimal dosimetry results are obtained, as we routinely perform in patients undergoing upfront GKRS for smaller tumors [41 (link), 60 (link)]. The stereotactic irradiation was delivered using the Leksell Gamma Knife® Perfexion™ (Elekta Instruments AB, Stockholm, Sweden). The procedure was performed on an ambulatory basis.
+ Open protocol
+ Expand
3

Rat Model of Arteriovenous Malformation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experiments involving animals were approved by the Macquarie University Animal Care and Ethics Committee (Sydney, Australia) under approval numbers 2014/013 (1 April 2014) and 2014/053 (1 January 2015). Animal experiments were performed in accordance with committee guidelines and the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. The rat AVM model is formed in Sprague–Dawley rats by surgically anastomosing the rostral end of the left jugular vein to the center of the left common carotid artery, as has been described in detail previously [5 (link),15 (link),16 (link)]. The arteriovenous fistula and the arterialized veins (of the model AVM) are irradiated six weeks after creation in anesthetized animals using a single-fraction stereotactic radiosurgical dose, which delivers a minimum of 20 Gy to the margin of the defined AVM, to a peak value of 40 Gy at the center. This was administered using a Leksell Gamma Knife Perfexion (Elekta Instruments, Stockholm, Sweden) at Macquarie University Hospital (Sydney, Australia), as described previously [5 (link),15 (link)]. Sham-irradiated animals were treated identically but did not receive any radiation.
+ Open protocol
+ Expand
4

Stereotactic Radiosurgery for Brain Metastases

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Leksell Gamma Knife Perfexion (Elekta AB, Stockholm, Sweden) was used for the SRS. Patients were treated on both an outpatient and inpatient basis. All patients were treated with frame-based immobilization and MRI-based treatment planning, with plans developed under the supervision of a radiation oncologist, a medical physicist, and a neurosurgeon. The radiation dose was contingent on tumor diameter/volume, proximity to critical structures, history of prior surgery, and history of prior radiation treatment. Single-fraction SRS was used in all cases in this review. Radiation doses ranged from 10 to 24 Gy with a median dose of 20 Gy. The first follow-up was planned for 4–6 weeks after GKRS, and subsequent follow-up was generally planned at 3-month intervals. GKRS for patients with prior metastasectomy was delivered to the surgical cavity with margin. Patients with any form of insurance (Medicare, Medicaid, or private insurance) were accepted for treatment in our program, some patients with no insurance were also treated, although at our institution many of these patients received SRS using a separate robotic-based system due to the availability of a more flexible payment with that modality.
+ Open protocol
+ Expand
5

Leksell Gamma Knife Radiosurgery Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A treatment plan was generated using the Leksell GammaPlan (Elekta Instrument) system based on the findings from the thin-sliced MRI. Radiosurgery was performed using the Leksell Gamma Knife PERFEXION (Elekta Instrument AB, Stockholm, Sweden). The radiosurgery isodose and marginal dose prescribed were initially determined using the Radiation Therapy Oncology Group (RTOG) 90-05 dosing guidelines [27 (link)] and calculated during dose planning using the best-fit isodose method. The marginal dose was then optimized by reducing approximately 10–20% of the recommended doses, according to the individual patient history of previous radiotherapy and/or tumor size, to reduce the radiation-related side effects. The treatments were usually designed to deliver 50% of the maximum dose to the target margins in a single fraction. The final prescribed dose, expressed as a marginal dose and the associated treatment parameters, are summarized in Table 1.
+ Open protocol
+ Expand
6

SRS for Brain Metastases After Resection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Surgical resection was performed at the discretion of the neurosurgeon. SRS was performed in a single fraction in all cases using the Leksell Gamma Knife Perfexion (Elekta Instruments). Patients were immobilized by stereotactic headframe, followed by T1-weighted gadolinium-enhanced (T1Gd) and T2-weighted (T2W) MRI on a 1.5 T machine. Surgical cavities were outlined on the T2W MRI and any residual tumor or other BM identified with T1Gd MRI. A 2–3 mm margin was added to the resection cavity to obtain the clinical target volume (CTV).
Patients were recommended to have a clinical examination and MRI every 3 months for the first year after SRS unless clinically indicated at an earlier time, then every 3–6 months thereafter.
+ Open protocol
+ Expand
7

Hypo-fractionated Radiosurgery for Metastatic Lesions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Radiosurgery was performed with the Leksell Gamma Knife Perfexion from 2009 to 2015 or the Leksell Gamma Knife Icon (both Elekta AB, Stockholm, Sweden) from April 2016 onward. The 1.0-mm slices of T1-weighted and 2.0-mm slices of T2-weighted fluid-attenuated inversion recovery (FLAIR) contrast-enhanced MR images were obtained and transferred to the Leksell GammaPlan Software version 11.1.1 (Elekta AB). Patients with tumor volume larger than 10 cc, maximal tumor diameter > 3 cm and retreatment metastatic lesion were indicated for the hypo-fractionated radiotherapy33 (link)–35 (link). The gross target volume and clinical target volume were defined identically to the perimeter of T1 enhancement in MRI. The planning target volume or prescription isodose volume (PIV) was created with 0 mm margin in single or two fractionated radiosurgery and with 2 mm margin in three or four fractionated radiosurgery. The dosimetry planning was conducted in accordance with the Radiation Therapy Oncology Group 90–05 study guidelines36 (link),37 (link).
Among these indicators, PIV was used in the analysis as a radiosurgical factor. The irradiated volume, rather than the geometric volume of the tumor, has more potential to influence the clinical course of metastatic lesions.
+ Open protocol
+ Expand
8

Gamma Knife Surgery on Arteriovenous Fistula in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
An arteriovenous fistula (AVF) was created surgically in isoflurane-anesthetized 6-week old, male Sprague-Dawley rats (n = 48) by anastomosing the caudal end of the left external jugular vein to the left common carotid artery as described in detail previously [25 (link), 26 (link)]. The AVF was considered ready for Gamma Knife surgery (GKS) six weeks following creation. Anesthetized rats (n = 24) were treated using a single-fraction stereotactic radiosurgical dose administered using a Leksell Gamma Knife Perfexion (Elekta Instruments, Stockholm, Sweden) at Macquarie University Hospital (Sydney, Australia). GKS planning by axial full-body CT scanning with 3D reconstruction and subsequent treatment was performed as described [25 (link)], with the exception that a single marginal 15 Gy dose of radiation was delivered.
+ Open protocol
+ Expand
9

Gamma Knife Radiosurgery for Brain Lesions

Check if the same lab product or an alternative is used in the 5 most similar protocols
The GKRS procedure was performed using a Leksell Gamma Knife 4C model, before 2009, and a Leksell Gam- ma Knife Perfexion (Elekta AB) thereafter. Leksell Gam-maPlan was used for treatment planning. The application of the Leksell G-frame was performed in the patient's room after application of a local anesthetic solution. Following frame placement, high-resolution stereotactic MRI was performed for treatment planning. Precontrast and postcontrast (15-mg intravenous Gd) T1-weighted axial images were obtained with a slice thickness of 1.5 mm. Dose planning was performed by a neurosurgeon, radiation oncologist, and medical physicist. The target was defined as the contrast-enhancing lesion on the planning MR image. The mean tumor volume was 4.00 cm 3 (range 0.13-11.35 cm 3 ). The median prescribed dose was 13 Gy (range 11-15 Gy) to that isodose covering 90%-100% of the target.
During the treatment planning, CN V was not visible due to the tumor mass, making it impossible to determine the proximity of the trigeminal nerve to the tumor. This was the case for all patients.
+ Open protocol
+ Expand
10

Stereotactic Gamma Knife Irradiation of Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were irradiated with the Leksell Gamma Knife® Perfexion™ (Elekta; Stockholm, Sweden; http://www.elekta.com/), a state-of-the-art unit used for stereotactic irradiation of patients with malignant brain tumors. Mice were supported on a specially designed platform mounted to the stereotactic frame that attaches to the treatment couch of the Gamma Knife. Mice were anesthetized with a mixture of ketamine (25 mg/kg), acepromazine (5 mg/kg) and xylazine (5 mg/kg), injected intraperitoneally 5 min before the start of irradiation. 35 female Balb/c mice were irradiated with either 60 Gy or 50 Gy, as described below, and the resulting brain parenchymal changes were characterized by both MRI and histology.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!